Appellate authority confirms Aurobindo Pharma ₹155cr GST demand
Change
The Principal Commissioner of Customs and Central Tax (Appeals I), Hyderabad confirmed orders imposing GST, interest and a matching penalty totaling more than ₹155 crore against Aurobindo Pharma.
Why it matters
The confirmed demand comprises a GST liability of ₹77,61,35,242, interest, and a matching penalty of ₹77,61,35,242, totaling more than ₹155 crore. Aurobindo Pharma has paid ₹23,71,71,782 under protest. The company reversed input tax credit (ITC) of ₹8,78,23,385, which has been accepted by tax authorities. The Principal Commissioner (Appeals I), Hyderabad confirmed orders issued by the Additional Commissioner of Central Tax, Ranga Reddy GST Commissionerate. Aurobindo Pharma intends to file an appeal in the Goods and Services Tax Appellate Tribunal (GSTAT).
Implications
- • A consolidated GST demand of ₹77,61,35,242 and an equal penalty of ₹77,61,35,242 is recorded against the company.
- • A payment of ₹23,71,71,782 is recorded as paid under protest.
Unlock the decision layer.
Go beyond headlines — see impact, exposure, and timing.
- Implications: What actually changes downstream.
- Who is affected: Which teams or operators are exposed.
- What to watch: Deadlines, triggers, and next moves.
- Real-time alerts: Know the moment a change is published.
- Ask AI: Clarify any brief instantly, in context.
14-day free trial. Full access. No credit card required.
Start free trial
Source
Topics